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Demonstration that a Lectin-like Receptor (gp90 MEL) 
Directly Mediates Adhesion of Lymphocytes 
to High Endothelial Venules of Lymph Nodes 
Joyce S. Geotfroy and Steven D. Rosen 
Department ofAnatomy, University of California, San Francisco, California 94143-0452 
Abstract. Lymphocyte migration from the blood into 
most secondary lymphoid organs is initiated by a 
highly selective adhesive interaction with the endo- 
thelium of specialized blood vessels known as high en- 
dothelial venules (HEV). The propensity of lympho- 
cytes to migrate to particular lymphoid organs is 
known as lymphocyte homing, and the receptors on 
lymphocytes that dictate interactions with HEV at par- 
ticular anatomical sites are designated "homing recep- 
tors". Based upon antibody blockade xperiments and 
cell-type distribution studies, a prominent candidate 
for the peripheral lymph node homing receptor in 
mouse is the =90-kD cell surface glycoprotein 
(gp90 MEL) recognized by the monoclonal antibody 
MEL-14. Previous work, including sequencing of a 
cDNA encoding for this molecule, supports the possi- 
bility that gp90 uEL is a calcium-dependent lectin-like 
receptor. Here, we show that immunoaffinity-purified 
gp90 MEL interacts in a sugar-inhibitable manner with 
sites on peripheral lymph node HEV and prevents at- 
tachment of lymphocytes. Lymphocyte attachment to 
HEV in Peyer's patches, a gut-associated lymphoid or- 
gan, is not affected by gp90 MEL. The results demon- 
state that gp90 MEL, as a lectin-like receptor, directly 
bridges lymphocytes to the endothelium. 
VUPHOCVTES move extensively throughout the body, mi- 
grating from the blood into lymphoid organs and 
back to the blood again via lymphatics. The overall 
process, known as lymphocyte r circulation, is an essential 
component of immune surveillance as it brings potentially 
responsive lymphocytes into contact with antigens sequestered 
within secondary lymphoid organs (reviewed in Butcher, 
1986; Duijvestijn and Hamann, 1989; Ford, 1975; Stool- 
man, 1989; Woodruff et al., 1987; Yednock and Rosen, 
1989). Entry of blood-borne lymphocytes into all secondary 
lymphoid organs, except he spleen, is initiated by a highly 
specific ell-cell recognition event between lymphocytes and 
the endothelial cells of specialized postcapillary venules found 
within these organs (Gowans, 1959; Gowans and Knight, 
1964). These venules are characterized by having a cuboidal 
or high endothelial lining and are referred to as high endo- 
thelial venules (HEV).~ The adhesive interactions between 
lymphocytes and HEV have been studied in vivo with short 
term recirculation studies (reviewed in Butcher et al., 1980) 
and in vitro with the highly validated Stamper-Woodruff ad- 
herence assay (Stamper and Woodruff, 1976), in which via- 
ble lymphocytes, overlaid onto cryostat-cut sections of lym- 
phoid organs, selectively adhere to sectioned profiles of HEV. 
Three distinct adhesive specificities have been shown to ex- 
1. Abbreviations used in this paper: HEV, high endothelial venules; PN, pe- 
ripheral ymph node; PP, Peyer's patch. 
ist, one governing lymphocyte attachment toHEV in periph- 
eral lymph nodes (PN), another for gut-associated Peyer's 
patches (PP), and a recently identified specificity for lung- 
associated lymph nodes (Butcher et al., 1980; Chin et al., 
1983; Chin et al., 1984; Geoffroy et al., 1988). 2It has been 
postulated that the endothelial cells of HEV bear cell surface 
ligands that are distinctive for particular lymphoid organs or 
anatomically related collections of lymphoid organs (Butcher 
and Weissman, 1984). The ligands are the heterophilic adhe- 
sion partners for a set of complementary lymphocyte r cep- 
tors. Depending on a lymphocyte's developmental stage, class, 
subclass, and history of antigenic stimulation, the particular 
array of receptors expressed by the cell determines its ability 
to bind to and hence initiate extravasation across HEV in 
different anatomical sites (for review, see Butcher, 1986). 
"Homing receptor" is the designation applied to this set of 
lymphocyte adhesion receptors, reflecting their primary role 
in controlling the distinctive migratory or "homing" propen- 
sities of lymphocyte and lymphoma populations. The activ- 
ity of these specific adhesion molecules appears to be sup- 
plemented by accessory molecules such as LFA-1, which act 
to strengthen the lymphocyte-HEV interaction without con- 
tributing to target organ specificity (Hamann et al., 1988; 
Pals et al., 1988). The use of this system of highly refined 
2. Additional ymphocyte-endothelial adhesive specificities may regulate 
lymphocyte extravasation at sites of chronic inflammation such as inflamed 
joints (Jalkanen et al., 1986) and skin (Sackstein et al., 1988). 
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homing specificities is believed to lie in its potential to regu- 
late the exact mix of functional subpopulations which popu- 
late each lymphoid organ such that immune responses initi- 
ated within are appropriate and maximally efficient for the 
particular anatomical site (Butcher, 1986). 
A number of candidates have been identified for HEV- 
ligands in the mouse (Streeter et al., 1988a,b) and for lym- 
phocyte homing receptors in the mouse, rat, and human sys- 
tems (Chin et al., 1986; Gallatin et al., 1983; Holzmann et 
al., 1989; Jalkanen et al., 1986; Rasmussen et al., 1985; 
Woodruff et al., 1987). In the rat, evidence xists that hom- 
ing receptors are shed into lymph as soluble factors. One fac- 
tor, termed high endothelial binding factor (HEBFLN), pre- 
vents lymphocyte attachment o PN HEV while having no 
effect on attachment o PP HEV when it is prereacted with 
tissue sections (Rasmussen et al., 1985). The other identified 
factor, HEBFpp, has the opposite activity (Chin et al., 1986). 
In the mouse, the most extensively studied candidate for a 
homing receptor is the '~90-kD (i.e., gp90 mL) glycoprotein 
detected on the surface of lymphocytes by the MEL-14 mAb 
(Gallatin et al., 1983). Lymphocytes pretreated with this an- 
tibody are incapable of attaching to PN HEV but bind at con- 
trol levels to PP HEV. The cell surface level of gp90 uEL on 
various populations of normal lymphocytes and lymphomas 
correlates with their ability to bind to PN HEV (Gallatin et 
al., 1983; Reichert et al., 1983; Yednock et al., 1987a). In 
addition, our previous work has shown that a calcium-depen- 
dent, lectin-like receptor involved in PN homing is closely 
associated, and very likely identical, to gp90 mL (Yednoek 
et al., 1987b). In support of identity, cDNAs encoding 
gp90 ~sL predict a transmembrane glycoprotein with a cal- 
cium-dependent lectin domain at its extracellular amino ter- 
minus (Lasky et al., 1989; Siegelman et al., 1989). An EGF- 
like domain and two exact repeats of a complement regula- 
tory domain comprise the remainder of the exlracellular e- 
gion (Lasky et al., 1989; Siegelman et al., 1989). The pres- 
ent study confirms that gp90 M~L is an essential element of 
the PN homing receptor by showing that the purified antigen 
can interact with sites on PN HEV and prevent lymphocyte 
attachment in an organ-specific manner. Additionally, we pro- 
vide the first direct evidence that specific sugars and polysac- 
charides can block the biological activity of the isolated 
receptor. 
Materials and Methods 
Materials 
Frozen spleens from ICR and Swiss-Webster mice were obtained from 
Rockland, Inc. (Gilbertsville, PA) or Bioproducts for Science (Indianapolis, 
IN). Mesenteric lymph nodes and spleen were also dissected from ICR mice 
(Harland Sprague-Dawley, Inc., Indianapolis, IN). The Centriprep and Cen- 
tricon 30 were purchased from Amicon, Inc. (Danvers, MA). Phos- 
phorylated monosaccharides, cacodylic acid, cyanogen bromide-activated 
Sepharose-4B, PMSF, aprotinin, triethylamine, alpha l-acid glycoprotein, 
and BSA (Cohn V; BSA) were obtained from Sigma Chemical Co. (St. 
Louis, MO). Triton X-100 came from Boehringer Mannheim (Indianapolis, 
IN) and CHAPS was obtained from Calbiochem-Behring Corp. (La Jolla, 
CA). Paraformaldehyde was purchased from EM Science (Cherry Hill, 
N J). PPME was purified from Hansenula holstii core mannan, kindly 
provided by Dr. M. E. Slodki (U.S. Department of Agriculture, Northern 
Regional Center, Peoria, IL). The mnn 1 amd mnn 2 mannans were gener- 
ous gifts from Dr. C. E. Ballou (Department of Biochemistry, University 
of California, Berkeley, CA). The MEL-14 bybridoma was kindly provided 
by Dr. Eugene Butcher (Department of Pathology, Stanford University). 
Purification of Ann'gen 
The purification of gp90 MEL was achieved by a modification of a previ- 
ously described procedure (Lasky et al., 1989). The starting material was 
frozen mouse spleens or mesenteric lymph nodes. Tissues were minced with 
a razor blade and then homogenized with a Potter-Elvehjem tissue grinder 
in 5 ml of lysis buffer (2% Triton-X 100 in Dulbecco's phosphate buffered 
saline [PBS], containing 1 m_M PMSF, 1% aprotinin, and 0.02% NAN3) 
per gram (wet weight) tissue. Typical preparations u ed tissues from 200 
animals. The lysates were prepared, clarified, and precleared with rat 
serum-Sepharose 413as previously described (Lasky et al., 1989). The flow 
through from the rat-serum column was applied to a 4-ml column of 
Sepharose 4B conjugated with MEL-14 mAb (1 mg mAb/ml Sepharose) 
which had been equilibrated in lysis buffer. The column was washed con- 
secutively with 10 ml of lysis buffer followed by 30 ml of column buffer 
(10 mM CHAPS in PBS containing 1mM PMSF, I% aprotinin, and 0.02% 
NAN3). Antigen was released from the column in 15 ml of a low pH buffer 
(10 mM CHAPS, 100 mM glycine, 200 mM NaCI, 1% aprotinin, 1 mM 
PMSE 0.02% NAN3, pH 3) and collected into 1.5 ml of I M Tris-HCl (pH 
7.6) to neutralize the pH. After antigen release, the column was washed with 
20 mM triethylamine, 200 mM NaCI (pH 11) and reequilibrated with 
column buffer. The antigen, which was diluted to 50 ml in column buffer, 
was re.applied to the column, and the elution procedure was repeated. The 
purified protein was concentrated in two steps by sequential use of Cen- 
triprep 30 and Centricon 30 concentrators. Purity was evaluated by SDS- 
PAGE with visualization by silver staining (Merrill et al., 1981). Based upon 
comparisons with alpha 1 acid glucoprotein standards, typical yields were 
25-35 tLg glO0 MEL per 200 spleen and 20-30 ~g from mesenteric lymph 
nodes from 200 animals. No difference could be detected in the biological 
activity of gp90 MEL isolated from the two sources. The molecular weight 
distribution of antigen isolated from spleen was slightly broader than that 
from mesenteric lymph nodes. 
Binding Assay 
In a series of experiments, it was determined that the presence of 250 #M 
CHAPS in the assay medium did not interfere with the viability of lympho- 
cytes (as assessed by Trypan blue exclusion) or their ability to bind to HEV 
in sections of PN and PP. Purified gp90 MeL in column buffer was equili- 
brated with 500 #M CHAPS in RPMI 1640 (CHAPS/RPMI) by several ex- 
changes in a Centricon 30 concentrator. BSA was added to antigen solutions 
to a final concentration f I mg/ml. Control buffer solutions were prepared 
in the same way. One part of antigen solution was mixed with one part of 
RPMI (2 mg/ml BSA) containing potential inhibitors (phosphorylated sug- 
ars, polysaccharides, or MEL-14 mAb), and the mixture was incubated for 
1 h at 40C before incubation with the tissue sections (see below). PNs and 
PPs, dissected from ICR mice, were mounted on a cushion of gum traga- 
canth and snap-frozen i 2-methylbutane cooled in a liquid nitrogen bath. 
Cryostat-cut sections (10 tim) were picked up on epoxy-coated well slides 
(Carlson Scientific, Inc., Peotone, IL). The slides were fixed in 1% parafor- 
maldehyde in0.1 M sodium cacodylate (pH 7.3) for 20 min at 4"C, and sub- 
sequently rinsed in PBS. Appropriate dilutions of purified antigen or control 
buffer were applied to the wells (75/~1 per well), and the slides were placed 
on a metal pan supported by an ice pack and rotated on an orbital shaker 
for 30 rain at 50 rpm. The slides were then washed in a 250 ml bath of PBS 
(40C) and then subjected to the Stamper-Woodruff in vitro adherence assay 
(Stamper and Woodruff, 1976) with the modifications described p~viously 
(Yednock et al., 1987b). Mesenteric lymph node lymphocytes (107 per ml 
in a volume of 100/zl per well) were used as test cells. At least four replicate 
sections were used for the control condition (buffer) and for each experi- 
mental condition. Values for lymphocytes bound per unit area HEV were 
determined by digital morphometry on a Bioquant image analyzer (R & M 
Biometrics, Nashville, TN). Samples were coded and evaluated blindly. At 
least 15 segments ofHEV were counted for each PN and PP section. In the 
different experiments, control evels of binding ranged from 24 to 61 lym- 
phocytes per 100 square micrometers HEV for PN and from 30 to 67 lym- 
phocytcs per 100 square micrometers HEV for PP. 
Results 
Our overall approach was based upon one developed by 
Springer, Shaw, and their respective colleagues (Dustin et 
al., 1989; Plunker et al., 1987; Selvaraj et al., 1987) to 
study a receptor-ligand interaction that underlies a number 
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Figure 1. SDS-PAGE analysis ofpu- 
dried gp90 uEL. Antigen was purified 
from detergent lysates of mouse spleen 
by immunoattinity chromatography 
on a MEL-14 mAb column. The 
purified antigen was analyzed on a 
7.5% SDS gel with visualization by 
silver staining. The high molecular 
mass markers (Bio-Rad Laborato- 
ries, Cambridge, MA) were myosin 
(200 kD), beta-galactosidase (116 
kD), phosphorylase b (93 kD), BSA 
(66 kD), and ovalbumin (45 kD). 
of T-lymphocyte adhesion events including the binding of 
cytotoxic T-cells to target cells and the attachment of thymo- 
cytes to thymic epithelial ceils. In these studies, solubilized 
receptor from T-cells (CD2 glycoprotein) was shown to in- 
teract with ligand sites (i.e., LFA-3 glycoprotein) on partner 
125 
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Pretremed S~'dons Pre~remted Lymphocyt~ 
Figure 2. The effect of purified gp90 MEL on lymphocyte attach- 
ment o PN HEV. Cryostat-cut sections f peripheral lymph node 
were exposed to 1/~g of gp90 uEL in 75 #1 buffer (250 ~M CHAPS, 
1 mg/rnl BSA in RPMI) or buffer alone for 30 rain at 4°C. The sec- 
tions were washed in a large volume of PBS and then tested for their 
ability to support binding of untreated lymphocytes as described in 
Materials and Methods. For lymphocyte treatments, lymphocytes 
(4 x 106) from mesenteric lymph nodes were suspended in 300 t~l 
of gp90 uEL in buffer (13 t~g/ml) or in buffer alone for 30 min at 
4"C. The lymphocytes were washed 3 x in PBS and tested for bind- 
ing to untreated PN sections. Values for lymphoeytes bound per unit 
area HEV were measured and computed as a percent of control 
binding, referenced to the level of binding in the buffer control. 
Dark bars represent treatments with buffer control and open bars 
represent treatments with gp90 MEL. The error bars represent SEMs 
based upon three independent replicates. 
cells and block intercellular adhesion. In reciprocal experi- 
ments, isolated LFA-3 was demonstrated to interact with CD2 
on intact T-cells and block adhesion. A key to these studies 
was that the solubility and biological activity of the purified 
transmembrane glycoproteins could be maintained in a low 
detergent concentration, which was compatible with the via- 
bility of the test cells. Guided by the strategy of these xperi- 
ments, we wished to determine whether purified gp90 M~L 
could bind to HEV in cryostat-eut sections of PN and prevent 
lymphocyte attachment in the Stamper-Woodruff in vitro ad- 
herence assay. With mouse spleen and mesenteric lymph 
nodes as the sources of antigen, purification was achieved by 
immunoaflinity chromatography on a MEL-14 mAb column 
(see Materials and Methods). In a typical preparation, the 
purified material was resolved by SDS-PAGE as a major dif- 
fuse band at 90 kD and variable amounts of a minor (<10%) 
180-kD band (Fig. 1). The larger component appears to be 
a dimer of the smaller, since upon electroelution a d reelec- 
trophoresis t is substantially converted to the 90-kD form 
(Brian Williams and S. Rosen, unpublished observations). 
We chose CHAPS as the detergent for the purified antigen, 
because it is relatively nondenaturing and can be readily re- 
moved by membrane filtration. We determined (data not 
shown) that the maximum concentration f CHAPS compat- 
ible with the Stamper-Woodruff assay was 250/~M. When the 
assay was performed at this concentration r lower, the den- 
sity of lymphocytes bound per unit area of HEV was equiva- 
lent to that in detergent-free buffer. 
Cryostat-cut sections of PN were pretreated for 30 rain 
with gp90 MEL in 250 t~M CHAPS or with this concentration 
of detergent alone. The sections were washed in detergent- 
free medium and tested for their ability to support lympho- 
cyte attachment to HEV. As shown in Fig. 2, lymphocyte 
binding to PN HEV was almost completely blocked after x- 
posure of the sections to 1 ~g of gp90 uEL ('~100 nM). In 
contrast, pre-exposure of lymphocytes to the same antigen 
concentration followed by washing of the cells resulted in no 
decrement in lymphocyte attachment toHEV. Thus, the iso- 
lated antigen exerted its inhibitory effect on the HEV and not 
the lymphocyte, consistent with the suspected role of gp90 M~- 
as a lymphocyte-associated adhesive receptor. 
Although the antigen preparations were >90 % pure (Fig. 
1), it was essential to demonstrate that the inhibitory activity 
of the purified antigen was, in fact, due to gp90 M~ and not 
to a contaminant. To address this issue, PN sections were 
pretreated with purified gp90 MEL in the presence and ab- 
sence of MEL-14 mAb. After the preincubation step, the sec- 
tions were washed extensively so that antibody would not be 
available to react with the test lymphocytes. As shown in Fig. 
3, the antibody completely prevented the inhibitory activity 
of the purified antigen. Thus, the active constituent inthe im- 
munoisolated material must be the antigen itself. 
As reviewed above, gp90 uEL is believed to be involved in 
organ-specific lymphocyte adhesion to HEV. It was therefore 
of interest to determine whether isolated gp90 ~EL would in- 
terfere with lymphocyte attachment to PP HEV as it did with 
attachment to PN. When sections of PP were pretreated with 
up to 2 t~g of purified antigen, there was no inhibition of sub- 
sequent lymphocyte attachment (Fig. 4). With the same anti- 
gen preparation tested in parallel, 0.1 #g of antigen produced 
'~50% inhibition of lymphocyte attachment to PN HEV, and 
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Figure 3. The effect of MEL-14 mAb on the adhesion-blocking ac-
tivity of purified gp90 MEL. Sections of peripheral node were prein- 
cubated with control buffer, or 2 ttg of MEL-14 mAb, 1 ttg of 
gp90 ueL, or 1 ~,g of gp90 MeL + 2 #g of MEL-14 mAb. Sections 
were then washed and subjected to the lymphocyte binding assay. 
Values of lymphocytes bound per unit area HEV were computed as 
a percent of control binding, referenced tothe level of binding in 
the buffer control. The error bars represent SEMs based upon four 
independent replicates. The MEL-14 mAb alone treatment was in- 
cluded to establish t at he section washing procedure was adequate 
to reduce the antibody concentration to a level that did not interfere 
with lymphocyte binding. 
at 0.25 #g and above, inhibition was >80% (Fig. 4). Thus, 
gp90 uEL was at least 20-fold more active on the PN HEV sites 
than the PP HEV sites. Representative micrographs illustrat- 
ing the differential effects of antigen on lymphocyte attach- 
ment activity of the two kinds of HEV are shown in Fig. 5. 
The demonstration above that purified gp90 ~L has bio- 
logical activity allowed us to test directly the predicted lectin 
function of the molecule. Our previous work had shown that 
millimolar levels of nmnnose-6-phosphate (M6P) or of the 
structurally related fructose-l-phosphate (FIP) block lym- 
phocyte attachment toPN HEV by reacting with gp90 MsL or 
a closely associated molecule on the lymphocyte surface 
(Yednock et al., 1987a,b). If these effects were, in fact, 
through a direct interaction of the sugars with gpg0 MEL, 
then biological activity of isolated gp90 MsL should be com- 
peted by the same sugars. As shown in Fig. 6, 100 nM of ei- 
ther M6P (A) or F1P (B) largely prevented the blockade of 
PN HEV sites by gpg0 ~EL. Three control sugars, fructose- 
6-phosphate (A), galactose-6-phosphate, and glucose-6- 
phosphate (B), all previously shown to be relatively inactive 
in blocking lymphocyte attachment toPN HEV, did not an- 
tagonize the inhibitory activity of the isolated antigen. Com- 
petition experiments were also conducted with the M6P-rich 
mannan called PPME, a highly specific ligand for the active 
site of the PN homing receptor (Stoolman et al., 1984; Yed- 
nock et al., 1987b). As expected, this polysaccharide pre- 
vented the adhesion-blocking activity of gp90 M~L, whereas 
two control mannans (mnn 1 and mnn 2) were inactive (Fig. 7). 
Discussion 
Previous work has established that gp90 MEL is essential for 
PN homing, but heretofore, there has been no direct informa- 
tion bearing on whether this receptor could, itself, bind to 
HEV-ligands. The earlier esults, for example, are compati- 
ble with the possibility that gp90 M~ interacts with other 
lymphocyte surface molecules, either integral or peripheral 
membrane components, toform a homing receptor complex. 
Thus an element of the complex, other than gpg0 "eL, could 
form the actual bridge to the endothelium. The demonstra- 
tion above that isolated glO0 M~ can react with HEV and 
block the lymphocyte attachment activity of the HEV leads 
to the unequivocal conclusion that gp90 u" is capable of a 
direct binding interaction with HEV ligands. Moreover, this 
interaction is organ specific as established by the selective in- 
activation of PN sites as compared to PP sites. Thus, the in- 
formation required for the selective interaction of lympbo- 
cytes with the endothelium of PN HEV resides, at least in 
part, within the ~90 MEL molecule. Determining whether 
gp90 M~L, by itself, is capable of mediating the lymphocyte- 
HEV adhesive interaction will require reconstitution experi- 
ments with the purified glycoprotein or alternatively, trans- 
fection experiments with its eDNA. Although gp90 u~L may 
be sufficient for the interaction, it seems probable, in light 
of results from this system (Hamann et al., 1988; Pals et al., 
1988) and from related systems (Goverman et al., 1986; 
Springer et al., 1987), that general adhesion molecules (e.g., 
LFA-1) may be necessary to supplement the molecules con- 
ferring target organ-specificity (e,g,, gp90MeL). 
Our finding that isolated gp90 ~a~L blocks the adhesive ii- 
gands of PN HEV is highly reminiscent of the activity of 
HEBFLN in the rat system (Chin et al., 1983; Chin et al., 
1984; Rasmussen et al., 1985). This factor was originally 
detected as a soluble factor in lymph fluid. It is apparently 
derived by a shedding process from integral membrane com- 
ponents of the lymphocyte plasma membrane. In this regard, 
it is noteworthy that brief incubation of mouse lymphocytes 
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Figure 4. Lymphocyte binding to PN and PP HEV after pretreat- 
merit of sections with gp90 MEL. Sections of peripheral node (PN) 
and Peyer's patches (PP) were pre~ with the indicated amounts 
of purified gp90 MeL, washed, and then tested for their ability to 
support lymphocyte attachment toHEV. Lymphocytes bound per 
unit area of HEV was computed as a percent of control binding, 
referenced to the buffer control (i.e., no gp90MEL). Error bars 
reflect SEMs for four replicate sections for each tissue type. 
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Figure 5. Lymphocyte binding to PN and PP HEV after pretreatment of sections with gp90 MeL. PN (,4 and B) and PP (C and D) sections 
were preincubated with control buffer (A and C) or with 2/~g/section of gp90 MEL (B and D) for 30 rain before the binding assay. Micro- 
graphs show representative fields. The ark round cells are the exogenously added lymphocytes which have attached to the sections during 
the adhesion assay. Dashed lines have been drawn to outline the basement membranes of th  HEV. Bar, 100/zm. 
at 37°C results in the shedding of substantial mounts of solu- 
ble gpg0 uEL with a slightly decreased (4-5 kD) molecular 
mass (Yednock, T. A., J. S. Geoffroy, and S. D. Rosen, un- 
published). Both the soluble and membrane forms of HEBFLN 
are capable of blocking the activity of PN HEV ligands in 
an organ selective manner (Chin et al., 1984; Rasmussen et 
al., 1985). The molecular masses of the membrane form (135, 
63, and 40 kD) of HEBFLs (rat), as defined by immunopre- 
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Figure 6. Effects of phosphorylated monosaccharides on the adhe- 
sion-blocking activity of gp90 MEL. Purified gp90 uEL was mixed 
with control buffer or with sugars (100 nM final concentration) for 
60 min before the mixtures were applied (1 #g of glD0 MEL per sec- 
tion) to sections of PN. The sections were pretreated for 30 min, 
and washed before the binding assay. Data are expressed asa percent 
of control binding (no gp90 u~L) as above. Error bars denote SEMs 
for four replicate sections. ( 4) Mannose-6-phosphate (Man-6-P) or 
fructose-6-phosphate ( Fruc-6-P ). ( B ) Fructose-l-phosphate (Fruc- 
/-P), galactose-6-phosphate (Gal-6-P), or glucose-6-phosphate 
(GIc-6-P). 
cipitation with a monoclonal antibody (Rasmussen et al., 
1985), do not bear any obvious relationship to that of gpg0 M~ 
from mouse lymphocytes. Nonetheless, the striking func- 
tional parallels indicate the need for further exploration of 
the possibility that HEBFLN and gp90 ~EL might be species 
homologues. 
The present studies confirm previous predictions that 
gp90 mL functions as a lectin. M6P and F1P, two structur- 
ally related monosaccharides (Kaplan et al., 1977) that are 
active in blocking lymphocyte attachment toPN HEV, were 
shown to inhibit he activity of the isolated receptor, whereas 
three control phosphorylated monosaccharides were inactive 
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Figure 7. Effects ofpolysaccharides on the adhesion-blocking activ- 
ity of gpgO u~-. Purified gp90 MEL was incubated with control buffer 
or 100 #g/ml ofPPME, mrml marman, or mnrd mannan for 60 min 
before applying mixtures (1 #g of gp90 uEL per section) to sections 
of peripheral node. Sections were pretreated for 30 min and then 
rinsed thoroughly before the binding assay. Data are expressed as 
a percent of control binding (no gp9OUSL). Error bars denote SEMs 
for four replicate sections. 
at the same concentrations. Similarly, PPME (a M6P-rich 
polysaccharide that potently competes lymphocyte attach- 
ment to PN HEV) also selectively blocked the activity of 
isolated gp90 MEL. Of particular note is that antagonism of 
the isolated receptor by M6P or FIP was observed at I00 nM, 
a concentration that is •104 lower than required for inhibi- 
tion of lymphyocyte attachment to PN HEV. This dramatic 
potentiation might be explained by considerations of avidity. 
In the experiments with isolated receptor, the monosaccha- 
rides are competing the interaction of solubilized receptor 
molecules with sites on the HEV, whereas in the cell-cell 
adhesion assay, the lectin-like receptors that must be com- 
peted are presented in a highly multivalent array on the lym- 
phocyte surface. 
The demonstration presented herein, that gp90 M~L can in- 
teract directly with sites on PN HEV focuses attention on the 
nature of the HEV-associated ligands for this receptor. In 
view of the mounting evidence that this receptor functions 
as a lectin, it is strongly suspected that the recognition deter- 
minant of its cognate HEV-ligand will be carbohydrate in na- 
ture. Evidence is already available that sialic acid residues 
are essential for the function of the PN HEV ligands, al- 
though it is not yet known whether this sugar contributes 
directly to the actual recognition determinant or instead has 
a modulatory role (Rosen et al., 1989; Rosen et al., 1985). 
One prominent candidate for the PN HEV ligand is the 92- 
kD HEV-associated antigen detected by the MECA-79 anti- 
body (Streeter et al., 1988b; Berg et al., 1989). This anti- 
body selectively stains HEV of PN and blocks lymphocyte 
attachment. Future work should address whether this antigen 
or a physically associated molecule xpresses a carbohydrate 
determinant that is recognized by gp90 uEL. The possibility 
exists that he EGF-like and complement regulatory domains 
of gp90 MEL might also contribute to the interaction with 
ligand molecules. The capability to produce recombinant 
forms of gp90 uEL in substantial quantities hould provide 
tools that expedite the identification and biochemical dissec- 
tion of the relevant endothelial molecules of PN HEV. Even- 
tually, the analysis will undoubtedly progress to the distinct, 
The Journal of Cell Biology, Volume 109, 1989 2468 
but presumably related HEV ligands at other anatomical lo- 
cations. 
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